View Item 

Show simple item record

The National Network of Depression Centers: progress through partnership

dc.contributor.authorGreden, John F.en_US
dc.date.accessioned2011-11-10T15:33:20Z
dc.date.available2012-10-01T18:34:21Zen_US
dc.date.issued2011-08en_US
dc.identifier.citationGreden, John F. (2011). "The National Network of Depression Centers: progress through partnership." Depression and Anxiety 28(8): 615-621. <http://hdl.handle.net/2027.42/86894>en_US
dc.identifier.issn1091-4269en_US
dc.identifier.issn1520-6394en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/86894
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.titleThe National Network of Depression Centers: progress through partnershipen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelPsychologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelSocial Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumRachel Upjohn Professor of Psychiatry and Clinical Neurosciences, University of Michigan Medical Center, 4250 Plymouth Road, Ann Arbor, MI 48109en_US
dc.contributor.affiliationumRachel Upjohn Professor of Psychiatry and Clinical Neurosciences, University of Michigan Medical Center, 4250 Plymouth Road, Ann Arbor, MI 48109en_US
dc.identifier.pmid21796738en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/86894/1/20862_ftp.pdf
dc.identifier.doi10.1002/da.20862en_US
dc.identifier.sourceDepression and Anxietyen_US
dc.identifier.citedreferenceKessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity and comorbidity of twelve‐month DSM‐IV disorders in the National Comorbidity Survey Replication (NCS‐R). Arch Gen Psychiatry 2005; 62: 617 – 627.en_US
dc.identifier.citedreferenceGreden JF. The burden of disease for treatment‐resistant depression. J Clin Psychiatry 2001; 16: 26 – 31.en_US
dc.identifier.citedreferenceLopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747 – 1757.en_US
dc.identifier.citedreferenceWorld Health Organization: The Global Burden of Disease 2004 Update. 2008. Available at: http://www.who.int/healthinfo/global_burden_disease/en. Accessed September 16, 2010.en_US
dc.identifier.citedreferenceGibbons RD, Hur K, Bhaumik DK, Mann JJ. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 2005; 62: 165 – 172.en_US
dc.identifier.citedreferenceGreden JF, Riba M, McInnis, editors. Treatment Resistant Depression: A Roadmap for Effective Treatment ( Review of Psychiatry Series; Oldham JM and Riba MB, series, editors). Washington, DC: American Psychiatric Press; 2011.en_US
dc.identifier.citedreferenceAmara SG, Grillner S, Insel T, Nutt D, Tsumoto T. Neuroscience in recession? Nat Rev Neurosci 2011; 12: 297 – 302.en_US
dc.identifier.citedreferenceCrowley Jr WF, Sherwood L, Salber P, Scheinberg D, Slavkin H, Tilson H, Reece EA, Catanese V, Johnson SB, Dobs A, Genel M, Korm A, Reame N, Bonow R, Grebb J, Rimoin D. Clinical research in the United States at a crossroads: proposal for a novel public‐private partnership to establish a national clinical research enterprise. J Am Med Assoc 2004; 291: 1120 – 1126.en_US
dc.identifier.citedreferenceAndrews G, Issakidis C, Sanderson K, Corry J, Lapsley H. Utilising survey data to inform public policy: comparison of the cost‐effectiveness of treatment of ten mental disorders. British Journal of Psychiatry 2004; 184: 526 – 533.en_US
dc.identifier.citedreferenceKaton WJ. Collaborative care: evidence‐based models that improve primary care depressive outcomes. CNS Spectr 2009; 14: 10 – 14.en_US
dc.identifier.citedreferenceTrivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores‐Wilson K, Biggs MM, Balasubramani GK, Fava M. Evaluation of outcomes with citalpopram for depression using measurement‐based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163: 28 – 40.en_US
dc.identifier.citedreferenceMarch J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S Clinical Coordinating Center, Duke Clinical Research Institute, Duke University Medical Center, Vitiello B, Severe J, NIH. Fluoxetine, cognitive‐behavioral therapy, and their combination for adolescents with depression. Treatment for Adolescent Depression Study (TADS) randomized controlled trial. J Am Med Assoc 2004; 292: 807 – 820.en_US
dc.identifier.citedreferenceInsel TR, Wang PS. The STAR*D trial: revealing the need for better treatments. Psychiatr Serv 2009; 60: 1466 – 1467.en_US
dc.identifier.citedreferenceUnutzer J. Evidence‐based treatments for anxiety and depression: lost in translation. Depress Anxiety 2008; 25: 726 – 729.en_US
dc.identifier.citedreferenceAmerican Cancer Society. Cancer Facts & Figures 2010, Estimated New Cancer Cases and Deaths by State, US, Atlanta, GA: American Cancer Society; 2010, p4. Retrieved May 26, 2011 from http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc‐026238.pdfen_US
dc.identifier.citedreference“Cancer Institute's New Chief Talks of Cutbacks.” New York Times August 17, 2006.en_US
dc.identifier.citedreferenceHorner MJ, Ries LAG, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK. (eds). Surveillance epidemiology and end results (SEER) cancer statistics review 1975–2006, http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009. Table 2.18: “Estimated United States Cancer Prevalence Counts on January 1, 2006”, All Cancer Sites (Invasive): prevalence within past 5 years. National Cancer Institute. Bethesda, MDen_US
dc.identifier.citedreferenceZisook S, Lesser I, Stewart JW, Wisniewski SR, Balasubramani GK, Fava M, Gilmer WS, Dresselhaus TR, Thase ME, Nierenberg AA, Trivedi MH, Rush AJ. Effect of age at onset on the course of major depressive disorder. Am J Psychiatry 2007; 164: 1539 – 1546.en_US
dc.identifier.citedreferenceJudd LL, Paulus MJ, Schettler PJ, Akiskal HS, Endicott J, Leon AC, Maser JD, Mueller T, Solomon DA, Keller MB. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 2000;157: 1501 – 1504.en_US
dc.identifier.citedreferenceGreden JF, editor. Treatment of recurrent depression ( Review of Psychiatry Series Vol 20; Oldham JM, Riba MB, editors). Washington, DC: American Psychiatric Press; 2001.en_US
dc.identifier.citedreferenceGeddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361: 653 – 661.en_US
dc.identifier.citedreferenceReynolds CF, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, Houck PR, Mazumdar S, Butters MA, Stack JA, Schlernitzauer MA, Whyte EM, Gildengers A, Karp J, Lenze E, Szanto K, Bensasi S, Kupfer DJ. Maintenance treatment of major depression in old age. N Engl J Med 2006; 354: 1130 – 1138.en_US
dc.identifier.citedreferenceGolberstein E, Eisenberg D, Gollust SE. Perceived stigma and mental health care seeking. Psychiatr Serv 2008; 59: 392 – 399.en_US
dc.identifier.citedreferenceBerwick DM. Disseminating innovations in health care. J Am Med Assoc 2003; 289: 1969 – 1975.en_US
dc.identifier.citedreferenceCuijpers P, van SA, Smit F, Mihalopoulos C, Beekman A. Preventing the onset of depressive disorders: a meta‐analytic review of psychological interventions. Am J Psychiatry 2008; 165: 1272 – 1280.en_US
dc.identifier.citedreferenceGoodman WK, Insel TR. Deep brain stimulation in psychiatry: concentrating on the road ahead. Biol Psychiatry 2009; 65: 263 – 266.en_US
dc.identifier.citedreferenceMathew SJ, Manji HK, Charney DS. Novel drugs and therapeutic targets for severe mood disorders. Neuropsychopharmacology 2008; 33: 2080 – 2092.en_US
dc.identifier.citedreferenceNational Child Traumatic Stress Network (NCTSN). The NCTSN mission and vision. Retrieved July 10, 2009, from http://www.nctsnet.org/nccts/nav.do?pid=abt_mven_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
20862_ftp.pdf
Size:
161.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.